Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: A cluster-randomized controlled trial

Pain

Volumn 158, Issue 12, 2017, Pages 2354-2363

  Lumley, Mark A ^a   Schubiner, Howard ^b,c   Lockhart, Nancy A ^a   Kidwell, Kelley M ^d   Harte, Steven E ^d,e   Clauw, Daniel J ^d,e   Williams, David A ^d,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PROVIDENCE HOSPITAL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cognitive behavioral therapy; Education; Emotional awareness; Emotional expression; Fibromyalgia; Randomized clinical trial

Indexed keywords

ADULT; ANXIETY; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; EDUCATION; EMOTIONAL AWARENESS AND EXPRESSION THERAPY; FEMALE; FIBROMYALGIA; HUMAN; INTENTION TO TREAT ANALYSIS; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PAIN SEVERITY; PATIENT-REPORTED OUTCOME; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; AWARENESS; BEHAVIOR; COGNITIVE THERAPY; COMPLICATION; EMOTION; PAIN MEASUREMENT; PHYSIOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AWARENESS; BEHAVIOR; COGNITIVE THERAPY; DEPRESSION; EMOTIONS; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85041775271     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000001036     Document Type: Article

References (68)

1. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom 2009;78: 265-74.
2. Ablin J, Fitzcharles MA, Buskila D, Shir Y, Sommer C, Hauser W. Treatment of fibromyalgia syndrome: Recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med 2013;2013:7.
3. Baliki Marwan N, Apkarian AV. Nociception, pain, negative moods, and behavior selection. Neuron 2015;87:474-91.
4. Barnes SA, Mallinckrodt CH, Lindborg SR, Carter MK. The impact of missing data and how it is handled on the rate of false-positive results in drug development. Pharm Stat 2008;7:215-25.
5. Bennett RM, Burckhardt CS, Clark SR, O'Reilly CA, Wiens AN, Campbell SM. Group treatment of fibromyalgia: A 6 month outpatient program. J Rheumatol 1996;23:521-8.
6. Bernardy K, Klose P, Busch AJ, Choy EHS, Hauser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 2013:CD009796.
7. Beutler LE, Daldrup RJ, Engle D, Oro'-Beutler ME, Meredith K, Boyer JT. Effects of therapeutically induced affect arousal on depressive symptoms, pain and beta-endorphins among rheumatoid arthritis patients. PAIN 1987;29:325-34.
8. Broderick JE, Junghaenel DU, Schwartz JE. Written emotional expression produces health benefits in fibromyalgia patients. Psychosom Med 2005; 67:326-34.
9. Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiatry Med 2001;31:127-46.
10. Burger AJ, Lumley MA, Carty JN, Latsch DV, Thakur ER, Hyde-Nolan ME, Hijazi AM, Schubiner H. The effects of a novel psychological attribution and emotional awareness and expression therapy for chronic musculoskeletal pain: A preliminary, uncontrolled trial. J Psychosom Res 2016;81:1-8.
11. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
12. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M, Group PC. The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Group during its first two years. Med Care 2007;45:S3-S11.
13. Clauw DJ. Fibromyalgia: A clinical review. JAMA 2014;311:1547-55.
14. Cleeland C. The brief pain Inventory: User guide. Houston, TX: MD Anderson Cancer Center, 2009.
15. Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2016;9: CD011790.
16. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/ expectancy questionnaire. J Behav Ther Exp Psychiatry 2000;31:73-86.
17. Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess 1985;49:71-5.
18. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-21.
19. Eccleston C, Crombez G. Advancing psychological therapies for chronic pain. F1000Res 2017;6:461.
20. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. Amer Psychol 2014;69:153-66.
21. Finan PH, Zautra AJ, Davis MC. Daily affect relations in fibromyalgia patients reveal positive affective disturbance. Psychosom Med 2009;71: 474-82.
22. Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA. Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. PAIN 2010;149:373-8.
23. Gillis ME, Lumley MA, Mosley-Williams A, Leisen JCC, Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: A randomized trial. Ann Behav Med 2006;32:135-46.
24. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: A meta-analysis. PAIN 2010;151:280-95.
25. Goldenberg DL, Kaplan KH, Nadeau MG, Brodeur C, Smith S, Schmid CH. A controlled study of a stress-reduction, cognitive-behavioral treatment program in fibromyalgia. J Musculoskel Pain 1994;2:53-66.
26. Gracely RH, Schweinhardt P. Programmed symptoms: Disparate effects united by purpose. Curr Rheumatol Rev 2015;11:116-30.
27. Hassett AL, Williams DA. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol 2011; 25:299-309.
28. Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J, Petermann F, Prothmann U, Winkelmann A, Schmutzer G, Brähler E, Glaesmer H. Posttraumatic stress disorder in fibromyalgia syndrome: Prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. PAIN 2013;154:1216-23.
29. Häuser W, Henningsen P. Fibromyalgia syndrome: A somatoform disorder? Eur J Pain 2014;18:1052-59.
30. Hsu MC, Schubiner H, Lumley MA, Stracks JS, Clauw DJ, Williams DA. Sustained pain reduction through affective self-awareness in fibromyalgia: A randomized controlled trial. J Gen Int Med 2010;25: 1064-70.
31. Jones GT, Power C, Macfarlane GJ. Adverse events in childhood and chronic widespread pain in adult life: Results from the 1958 British Birth Cohort Study. PAIN 2009;143:92-6.
32. Keefe FJ, Caldwell DS, Williams DA, Gil KM, Mitchell D, Robertson C, Martinez S, Nunley J, Beckham JC, Crisson JE, Helms M. Pain coping skills training in the management of osteoarthritic knee pain: A comparative study. Behav Ther 1990;21:49-62.
33. Kenward MG, Molenberghs G. Last observation carried forward: A crystal ball? J Biopharm Stat 2009;19:872-88.
34. Lane RD, Ryan L, Nadel L, Greenberg L. Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: new insights from brain science. Behav Brain Sci 2015;38:e1.
35. Lane RD, Waldstein SR, Critchley HD, Derbyshire SWG, Drossman DA, Wager TD, Schneiderman N, Chesney MA, Jennings JR, Lovallo WR, Rose RM, Thayer JF, Cameron OG. The rebirth of neuroscience in psychosomatic medicine, Part II: Clinical applications and implications for research. Psychosom Med 2009;71:135-51.
36. Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012;367: 1355-60.
37. Little RJ, Rubin DB. Statistical inference with missing data. New York, NY: Wiley, 2002.
38. Luborsky L, Diguer L, Seligman DA, Rosenthal R, Krause ED, Johnson S, Halperin G, Bishop M, Berman JS, Schweizer E. The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy. Clin Psychol Sci Pract 1999;6:95-106.
39. Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, Levitt JT, Seligman DA, Krause ED. The Dodo Bird Verdict is alive and well-mostly. Clin Psychol Sci Pract 2002;9:2-12.
40. Lumley MA, Cohen JL, Borszcz GS, Cano A, Radcliffe AM, Porter LS, Schubiner H, Keefe FJ. Pain and emotion: A biopsychosocial review of recent research. J Clin Psychol 2011;67:942-68.
41. Lumley MA, Cohen JL, Stout RL, Neely LC, Sander LM, Burger AJ. An emotional exposure-based treatment of traumatic stress for people with chronic pain: Preliminary results for fibromyalgia syndrome. Psychother Theor Res Pract Train 2008;45:165-72.
42. Lumley MA, Keefe FJ, Mosley-Williams A, Rice JR, McKee D, Waters SJ, Partridge RT, Carty JN, Coltri AM, Kalaj A, Cohen JL, Neely LC, Pahssen JK, Connelly MA, Bouaziz YB, Riordan PA. The effects of written emotional disclosure and coping skills training in rheumatoid arthritis: A randomized clinical trial. J Consult Clin Psychol 2014;82:644-58.
43. Moore AR. What works for whom? Determining the efficacy and harm of treatments for pain. PAIN 2013;154:S77-86.
44. Morley S, Williams A, Eccleston C. Examining the evidence about psychological treatments for chronic pain: Time for a paradigm shift? PAIN 2013;154:1929-31.
45. Moseley GL, Butler DS. Fifteen years of explaining pain: The past, present, and future. J Pain 2015;16:807-13.
46. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385-401.
47. Rosenthal R, Rownow RL. Essentials of behavioral research: Methods and data analysis. Boston, MA: McGraw-Hill Humanities Social, 1991.
48. Sayar K, Gulec H, Topbas M. Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol 2004;23:441-48.
49. Scheidt CE, Waller E, Endorf K, Schmidt S, König R, Zeeck A, Joos A, Lacour M. Is brief psychodynamic psychotherapy in primary fibromyalgia syndrome with concurrent depression an effective treatment? A randomized controlled trial. Gen Hosp Psychiatry 2013;35:160-67.
50. Schubiner H, Betzold M. Unlearn your pain: A 28-day process to reprogram your brain. Pleasant Ridge, MI: Mind-Body Pubishing, 2016.
51. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A. Development and validation of a multiple ability self-report questionnaire. J Clin Exper Neuropsychol 1994;16:93-104.
52. Selfridge N, Peterson F. Freedom from fibromyalgia: The 5 week program proven to conquer pain. New York, NY: Three Rivers Press, 2001.
53. Slavin-Spenny O, Lumley M, Thakur E, Nevedal D, Hijazi A. Effects of anger awareness and expression training versus relaxation training on headaches: A randomized trial. Ann Behav Med 2013;46:181-92.
54. Spitzer RL, Kroenke K, Williams JW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Int Med 2006; 166:1092-97.
55. Thieme K, Gromnica-Ihle E, Flor H. Operant behavioral treatment of fibromyalgia: A controlled study. Arthr Care Res 2003;49:314-20.
56. Turk DC, Okifuji A, Sinclair JD, Starz TW. Interdisciplinary treatment for fibromyalgia syndrome: Clinical and statistical significance. Arthr Care Res 1998;11:186-95.
57. Van Houdenhove B, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep 2005;7:365-70.
58. Van Houdenhove B, Luyten P, Tiber Egle U. Stress as a key concept in chronic widespread pain and fatigue disorders. J Musculoskel Pain 2009; 17:390-99.
59. Van Houdenhove BV, Luyten P. Fibromyalgia and related syndromes characterised by stress intolerance and pain hypersensitivity: Do we need a new nosology? Curr Rheumatol Rev 2007;3:304-8.
60. van Middendorp H, Lumley MA, Jacobs JWG, van Doornen LJP, Bijlsma JWJ, Geenen R. Emotions and emotional approach and avoidance strategies in fibromyalgia. J Psychosom Res 2008;64:159-67.
61. Varinen A, Kosunen E, Mattila K, Koskela T, Sumanen M. The relationship between childhood adversities and fibromyalgia in the general population. J Psychosom Res 2017;99:137-42.
62. Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St. Sauver J. Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthr Care Res 2013;65:786-92.
63. Ware JEJ, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
64. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988;54:1063-70.
65. Williams DA, Cary MA, Groner KH, Chaplin W, Glazer LJ, Rodriguez AM, Clauw DJ. Improving physical functional status in patients with fibromyalgia: A brief cognitive behavioral intervention. J Rheumatol 2002;29:1280-86.
66. Williams DA, Kuper D, Segar M, Mohan N, Sheth M, Clauw DJ. Internetenhanced management of fibromyalgia: A randomized controlled trial. PAIN 2010;151:694-702.
67. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38:1113-22.
68. Yunus MB. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthr Rheum 2007;36:339-56.